Skip to main content
. 2010 Jul-Aug;72(4):497–500. doi: 10.4103/0250-474X.73929

TABLE 1.

EFFECT OF MICS OF COMPOUND ON TEST BACTERIA AND YEAST LIKE FUNGI

Concn μg/ml Zone of inhibition (mm)
Ps. a P. v E. c S. c Kl. p S. a Rh C. a
200 28±0.88d 15±0.33c 18±0.57c 16±0.57c 19±0.88c 15±0.88c 19±0.66c 15±0.33c
400 34±0.57d 17±0.57c 21±0.58d 17±0.57c 19±0.28c 20±0.57d 23±0.57d 19±0.57c
600 35±0.57d 20±0.51d 24±0.51d 19±0.88c 22±0.57d 25±0.57d 27±0.57d 20±0.88d
* 29±0.66d 14±0.33b 20±0.57d 29±0.57d 22±0.57d 16±0.88c NT NT
** 32±0.57d 17±0.57c 23±0.57d 38±0.57d 22±0.57d 22±0.57d NT NT
*** NT NT NT NT NT NT 30±0.57d 32±0.57d
**** NT NT NT NT NT NT 35±0.57d 33±0.57d

a= weak activity;

b= moderate activity;

c=good activity;

d= strong activity.

Ps. a = Pseudomonas aeruginosa;

P. v = Proteus vulgaris;

E. c = Escherichia coli;

Rh= Rhodotorula spp;

Kl. p = Klebsiella sp.,;

S. a = Staphylococcus aureus;

S. c= Staphylococcus citrus;

C. a= Candida albicans.

*

Streptomycin 25 μg/ml;

**

gentamycin 10 μg/ml;

***

griseofulvin 40 μg/ml;

****

fluconazole 10 μg/ml; Values are mean inhibition zone (mm)±SD of three replicates; P<0.05

NT= Not tested.

HHS Vulnerability Disclosure